Diflucan (Fluconazole) Is NOT Appropriate for Bacterial Vaginosis
Diflucan (fluconazole) is an antifungal medication indicated exclusively for vaginal candidiasis (yeast infections), not bacterial vaginosis, and prescribing it for BV represents a fundamental misunderstanding of the infection's etiology. 1
Why Fluconazole Does Not Treat BV
Bacterial vaginosis is caused by anaerobic bacteria (Prevotella, Mobiluncus, Gardnerella vaginalis, Mycoplasma hominis) that replace normal Lactobacillus species—it is not a fungal infection. 2
Fluconazole is an azole antifungal that works exclusively against Candida species and other fungi; it has zero antibacterial activity against the polymicrobial anaerobic organisms responsible for BV. 1
Using fluconazole for BV will result in treatment failure and may delay appropriate antibiotic therapy, potentially increasing the risk of complications including pelvic inflammatory disease, preterm birth in pregnancy, and post-procedural infections. 2, 3
Correct First-Line Treatment for Bacterial Vaginosis
The CDC recommends metronidazole 500 mg orally twice daily for 7 days as the gold standard, achieving approximately 95% cure rates. 3
Alternative First-Line Regimens (Non-Pregnant Women)
Metronidazole 0.75% vaginal gel once daily for 5 days provides comparable efficacy to oral therapy. 3
Clindamycin 2% intravaginal cream nightly for 7 days is slightly less effective than metronidazole regimens but remains an acceptable first-line option. 3
Avoid the single-dose metronidazole 2 g regimen as first-line therapy because it yields only 84% cure rates versus 95% with the 7-day course. 3
Critical Patient Counseling
Patients must abstain from alcohol during metronidazole therapy and for 24 hours after the last dose to prevent disulfiram-like reactions (flushing, nausea, vomiting, headache). 3, 4
Clindamycin cream is oil-based and degrades latex condoms and diaphragms, potentially compromising contraceptive effectiveness. 3, 4
Treatment During Pregnancy
All symptomatic pregnant women require treatment because BV is associated with preterm rupture of membranes, preterm labor, chorioamnionitis, postpartum endometritis, and post-cesarean wound infection. 3, 4
Metronidazole 250 mg orally three times daily for 7 days is the recommended pregnancy regimen, using a lower dose to minimize fetal exposure while maintaining efficacy. 3
Clindamycin 300 mg orally twice daily for 7 days is an acceptable alternative when metronidazole is contraindicated. 3
Never use clindamycin vaginal cream in pregnancy—randomized trials demonstrated increased rates of preterm delivery and neonatal infections. 3
Multiple studies confirm no teratogenic or mutagenic risk with metronidazole use during pregnancy, including the first trimester. 3
When Fluconazole IS Appropriate: Vulvovaginal Candidiasis
Fluconazole 150 mg as a single oral dose is FDA-approved and highly effective for uncomplicated vaginal yeast infections, achieving 55% therapeutic cure rates (clinical resolution plus mycologic eradication) comparable to 7-day intravaginal azole regimens. 1
Distinguishing BV from Candidiasis Clinically
BV presents with homogeneous white-gray discharge, fishy odor (especially after KOH application), vaginal pH >4.5, and clue cells on microscopy—without vulvar inflammation. 2
Candidiasis presents with thick white "cottage cheese" discharge, vulvar pruritus and erythema, normal pH (≤4.5), and pseudohyphae/budding yeast on KOH preparation. 2
Microscopy or point-of-care testing is essential to differentiate these conditions before prescribing therapy. 2
Common Pitfalls to Avoid
Do not prescribe antifungals for BV based on the presence of vaginal discharge alone without confirming the diagnosis. 2
Do not treat sexual partners for BV—clinical trials demonstrate that partner therapy does not improve cure rates or reduce recurrence. 3, 4
Recognize that BV recurrence is common (50-80% within one year), so counsel patients to return if symptoms reappear rather than self-treating with over-the-counter antifungals. 4, 5
Screen and treat BV before surgical abortion—metronidazole administration markedly reduces post-abortion pelvic inflammatory disease. 3, 4